Quest Diagnostics to Release Third Quarter 2024 Financial Results on October 22, 2024
Quest Diagnostics (NYSE: DGX) has announced it will release its third quarter 2024 financial results on Tuesday, October 22, 2024, before the market opens. The company will host a conference call at 8:30 a.m. Eastern Time to discuss the results. Interested parties can access the call by dialing 888-455-0391 (U.S. and Canada) or 773-756-0467 (international) using the passcode "7895081". A live webcast and earnings release will be available on the company's investor relations website.
A replay of the call will be accessible online or by phone until November 5, 2024. Quest Diagnostics encourages listeners to review its periodic reports filed with the SEC, which include discussions of risk factors and historical financial information.
Quest Diagnostics (NYSE: DGX) ha annunciato che rilascerà i suoi risultati finanziari del terzo trimestre 2024 il martedì 22 ottobre 2024, prima dell'apertura del mercato. L'azienda ospiterà una conference call alle 8:30 a.m. Eastern Time per discutere i risultati. Le parti interessate possono accedere alla chiamata componendo il numero 888-455-0391 (Stati Uniti e Canada) o 773-756-0467 (internazionale) utilizzando il codice di accesso "7895081". Una trasmissione in diretta e il rilascio degli utili saranno disponibili sul sito web delle relazioni con gli investitori dell'azienda.
Una registrazione della chiamata sarà accessibile online o telefonicamente fino al 5 novembre 2024. Quest Diagnostics incoraggia gli ascoltatori a rivedere i suoi rapporti periodici depositati presso la SEC, che includono discussioni sui fattori di rischio e informazioni finanziarie storiche.
Quest Diagnostics (NYSE: DGX) ha anunciado que publicará sus resultados financieros del tercer trimestre de 2024 el martes 22 de octubre de 2024, antes de la apertura del mercado. La compañía realizará una llamada de conferencia a las 8:30 a.m. hora del Este para discutir los resultados. Las partes interesadas pueden acceder a la llamada marcando el 888-455-0391 (EE. UU. y Canadá) o el 773-756-0467 (internacional) utilizando el código de acceso "7895081". Una transmisión en vivo y el comunicado de ganancias estarán disponibles en el sitio web de relaciones con inversores de la empresa.
Una repetición de la llamada estará accesible en línea o por teléfono hasta el 5 de noviembre de 2024. Quest Diagnostics anima a los oyentes a revisar sus informes periódicos presentados ante la SEC, que incluyen discusiones sobre factores de riesgo e información financiera histórica.
Quest Diagnostics (NYSE: DGX)는 2024년 3분기 재무 결과를 2024년 10월 22일 화요일, 시장 개장 전에 발표할 것이라고 발표했습니다. 회사는 동부 표준시 기준 오전 8시 30분에 결과에 대해 논의하기 위한 전화 회의를 개최합니다. 관심 있는 분들은 888-455-0391(미국 및 캐나다) 또는 773-756-0467(국제)로 전화하여 접속 코드 "7895081"을 사용하여 회의에 참여할 수 있습니다. 생중계 및 수익 발표는 회사의 투자자 관계 웹사이트에서 확인할 수 있습니다.
전화 회의 녹음은 2024년 11월 5일까지 온라인이나 전화로 접근 가능합니다. Quest Diagnostics는 청취자에게 SEC에 제출된 정기 보고서를 검토할 것을 권장하며, 여기에는 위험 요소 및 과거 재무 정보에 대한 논의가 포함되어 있습니다.
Quest Diagnostics (NYSE: DGX) a annoncé qu'il publiera ses résultats financiers du troisième trimestre 2024 le mardi 22 octobre 2024, avant l'ouverture du marché. L'entreprise organisera une conférence téléphonique à 8h30 heure de l'Est pour discuter des résultats. Les parties intéressées peuvent accéder à l'appel en composant le 888-455-0391 (États-Unis et Canada) ou le 773-756-0467 (international) en utilisant le code d'accès "7895081". Un webinaire en direct et un communiqué de résultats seront disponibles sur le site Web des relations avec les investisseurs de l'entreprise.
Une rediffusion de l'appel sera accessible en ligne ou par téléphone jusqu'au 5 novembre 2024. Quest Diagnostics encourage les auditeurs à consulter ses rapports périodiques déposés auprès de la SEC, qui incluent des discussions sur les facteurs de risque et les informations financières historiques.
Quest Diagnostics (NYSE: DGX) hat angekündigt, dass es seine Finanzergebnisse für das dritte Quartal 2024 am Dienstag, den 22. Oktober 2024, vor der Markteröffnung veröffentlichen wird. Das Unternehmen wird um 8:30 Uhr Eastern Time eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen. Interessierte Parteien können sich unter 888-455-0391 (USA und Kanada) oder 773-756-0467 (international) mit dem Zugangscode "7895081" in die Sitzung einwählen. Eine Live-Übertragung und die Ergebnismitteilung werden auf der Webseite für Investor Relations des Unternehmens verfügbar sein.
Eine Aufzeichnung der Konferenz wird bis zum 5. November 2024 online oder telefonisch zugänglich sein. Quest Diagnostics ermutigt die Zuhörer, die regelmäßig eingereichten Berichte bei der SEC einzusehen, die Diskussionen zu Risikofaktoren und historischen Finanzdaten enthalten.
- None.
- None.
The conference call can be accessed by dialing 888-455-0391 within the
A replay of the call may be accessed online at www.QuestDiagnostics.com/investor or by phone at 800-839-5154 for domestic callers or 203-369-3358 for international callers; no passcode is required. Telephone replays will be available from approximately 10:30 a.m. Eastern Time on October 22, 2024 until midnight Eastern Time on November 5, 2024.
Anyone listening to the call is encouraged to read the company's periodic reports on file with the Securities and Exchange Commission, including the discussion of risk factors and historical results of operations and financial condition in those reports.
About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in
View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-release-third-quarter-2024-financial-results-on-october-22-2024-302258800.html
SOURCE Quest Diagnostics
FAQ
When will Quest Diagnostics (DGX) release its Q3 2024 financial results?
What time is Quest Diagnostics' (DGX) Q3 2024 earnings conference call?
How can investors access Quest Diagnostics' (DGX) Q3 2024 earnings call?
Until when will the replay of Quest Diagnostics' (DGX) Q3 2024 earnings call be available?
